Linguistic validation of the Japanese version of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)

被引:0
|
作者
Miyaji, Tempei [1 ]
Iioka, Yukiko [2 ]
Iwase, Satoru [1 ]
Goto, Yasushi [3 ]
Tsuboi, Masahiro [4 ]
Yamamoto, Daigo [5 ]
Odagiri, Hiroki [6 ]
Tsubota, Yu [7 ]
Kawaguchi, Takashi [8 ]
Anzai, Natsumi [9 ]
Mitchell, Sandra A. [10 ]
Basch, Ethan [11 ]
Yamaguchi, Takuhiro [12 ]
机构
[1] Univ Tokyo, Tokyo, Tokyo, Japan
[2] St Lukes Coll Nursing, Tokyo, Japan
[3] Natl Canc Ctr, Tokyo, Japan
[4] Natl Canc Ctr, East Hosp, Chiba, Japan
[5] Kansai Med Univ, Takii Hosp, Osaka, Japan
[6] Natl Hirosaki Hosp, Aomori, Japan
[7] Kansai Med Univ, Osaka, Japan
[8] Tokyo Univ Pharm & Life Sci, Tokyo, Japan
[9] Tokyo Univ Pharm & Life Sci, Tokyo, Japan
[10] NCI, Rockville, MD USA
[11] Univ N Carolina, Chapel Hill, NC USA
[12] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan
关键词
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
1037
引用
收藏
页码:78 / 78
页数:1
相关论文
共 50 条
  • [1] Japanese translation and linguistic validation of the us national cancer institute’s patient-reported outcomes version of the common terminology criteria for adverse events (Pro-ctcae)
    Miyaji T.
    Iioka Y.
    Kuroda Y.
    Yamamoto D.
    Iwase S.
    Goto Y.
    Tsuboi M.
    Odagiri H.
    Tsubota Y.
    Kawaguchi T.
    Sakata N.
    Basch E.
    Yamaguchi T.
    Journal of Patient-Reported Outcomes, 1 (1)
  • [2] Linguistic validation of the Spanish version of the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Benjamin Arnold
    Sandra A. Mitchell
    Lauren Lent
    Tito R. Mendoza
    Lauren J. Rogak
    Natalie M. Barragán
    Gordon Willis
    Mauricio Medina
    Suzanne Lechner
    Frank J. Penedo
    Jay K. Harness
    Ethan M. Basch
    Supportive Care in Cancer, 2016, 24 : 2843 - 2851
  • [3] Linguistic validation of the Spanish version of the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Arnold, Benjamin
    Mitchell, Sandra A.
    Lent, Lauren
    Mendoza, Tito R.
    Rogak, Lauren J.
    Barragan, Natalie M.
    Willis, Gordon
    Medina, Mauricio
    Lechner, Suzanne
    Penedo, Frank J.
    Harness, Jay K.
    Basch, Ethan M.
    SUPPORTIVE CARE IN CANCER, 2016, 24 (07) : 2843 - 2851
  • [4] Linguistic validation of the simplified Chinese version of the US National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™)
    Cheng KKF
    S. A. Mitchell
    N. Chan
    E. Ang
    W. Tam
    R. Kanesvaran
    BMC Cancer, 20
  • [5] Linguistic validation of the simplified Chinese version of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™)
    Cheng, K. K. F.
    Mitchell, S. A.
    Chan, N.
    Ang, E.
    Tam, W.
    Kanesvaran, R.
    BMC CANCER, 2020, 20 (01)
  • [6] Danish Translation and Linguistic Validation of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Baeksted, Christina
    Nissen, Aase
    Pappot, Helle
    Bidstrup, Pernille Envold
    Mitchell, Sandra A.
    Basch, Ethan
    Dalton, Susanne Oksbjerg
    Johansen, Christoffer
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2016, 52 (02) : 292 - 297
  • [7] Dutch translation and linguistic validation of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™)
    Veldhuijzen, Evalien
    Walraven, Iris
    Mitchell, Sandra A.
    Moore, Elizabeth Yohe
    McKown, Shawn M.
    Lauritzen, Matthew
    Kim, Katherine J.
    Belderbos, Jose S. A.
    Aaronson, Neil K.
    JOURNAL OF PATIENT-REPORTED OUTCOMES, 2020, 4 (01)
  • [8] Dutch translation and linguistic validation of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Veldhuijzen, Aaltje E.
    Belderbos, Jose S. A.
    Mitchell, Sandra A.
    McKown, Shawn M.
    Lauritzen, Matthew
    Moore, Elizabeth Yohe
    Kim, Katherine J.
    Walraven, His
    Aaronson, Neil K.
    QUALITY OF LIFE RESEARCH, 2018, 27 : S67 - S68
  • [9] Translation and linguistic validation of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™) in 10 languages
    Mitchell, Sandra
    Moore, Elizabeth Yohe
    McKown, Shawn
    Poepsel, Timothy
    Lauritzen, Matthew
    Campbell, Alicyn
    Piault, Elisabeth
    Zarzar, Katherine
    Kim, Katherine
    QUALITY OF LIFE RESEARCH, 2018, 27 : S25 - S25
  • [10] Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Basch, Ethan
    Reeve, Bryce B.
    Mitchell, Sandra A.
    Clauser, Steven B.
    Minasian, Lori M.
    Dueck, Amylou C.
    Mendoza, Tito R.
    Hay, Jennifer
    Atkinson, Thomas M.
    Abernethy, Amy P.
    Bruner, Deborah W.
    Cleeland, Charles S.
    Sloan, Jeff A.
    Chilukuri, Ram
    Baumgartner, Paul
    Denicoff, Andrea
    St Germain, Diane
    O'Mara, Ann M.
    Chen, Alice
    Kelaghan, Joseph
    Bennett, Antonia V.
    Sit, Laura
    Rogak, Lauren
    Barz, Allison
    Paul, Diane B.
    Schrag, Deborah
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (09):